Triple Therapy with Darbepoetin Alfa, Idebenone, and Riboflavin in Friedreich’s Ataxia: an Open-Label Trial-Reference-Cited by-同舟云学术

Triple Therapy with Darbepoetin Alfa, Idebenone, and Riboflavin in Friedreich’s Ataxia: an Open-Label Trial

Published:2013-04-27 Issue:5 Volume:12 Page:713-720
ISSN:1473-4222
Container-title:The Cerebellum
language:en
Short-container-title:Cerebellum

Author:

Arpa Javier,Sanz-Gallego Irene,Rodríguez-de-Rivera Francisco J.,Domínguez-Melcón Francisco J.,Prefasi Daniel,Oliva-Navarro Javier,Moreno-Yangüela Mar,Pascual-Pascual Samuel I.

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s12311-013-0482-y.pdf

Reference42 articles.

1. Dürr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, et al. Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med. 1996;335:1169–75.

2. Klockgether T, Lüdtke R, Kramer B, Abele M, Bürk K, Schöls L, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 1998;121:589–600.

3. Schulz JB, Boesch S, Bürk K, Dürr A, Giunti P, Mariotti C, et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. 2009;5:222–34.

4. Harding AE. Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and interfamilial clustering of clinical features. Brain. 1981;104:589–620.

5. Tsou AY, Paulsen EK, Lagedrost SJ, Perlman SL, Mathews KD, Wilmot GR, et al. Mortality in Friedreich ataxia. J Neurol Sci. 2011;307:46–9.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapeutic strategies for Friedreich Ataxia: a review of the available data;Expert Opinion on Pharmacotherapy;2024-03-23

2. Mitochondria-targeted antioxidants: coenzyme Q10, mito-Q and beyond;Molecular Nutrition and Mitochondria;2023

3. Friedreich ataxia: clinical features and new developments;Neurodegenerative Disease Management;2022-10

4. Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review;Therapeutic Advances in Rare Disease;2022-01

5. Riboflavin in Neurological Diseases: A Narrative Review;Clinical Drug Investigation;2021-04-22